Dominari Holdings Inc. financial data

Symbol
DOMH on Nasdaq
Location
725 Fifth Avenue, 22 Nd Floor, New York, New York
State of incorporation
Delaware
Fiscal year end
December 31
Former names
Aikido Pharma Inc. (to 12/21/2022), AIkido Pharma Inc. (to 12/21/2022), SPHERIX INC (to 3/13/2020), BIOSPHERICS INC (to 3/21/2001)
Latest financial report
Q1 2024 - May 9, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.67K % -51.1%
Debt-to-equity 9.03 % +157%
Return On Equity -44.5 % -55.5%
Return On Assets -40.8 % -47.7%
Operating Margin -1.07K %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 5.93M shares +22.6%
Common Stock, Shares, Outstanding 5.93M shares +24.8%
Entity Public Float 12.1M USD -60.7%
Common Stock, Value, Issued 9K USD 0%
Weighted Average Number of Shares Outstanding, Basic 6M shares +13%
Weighted Average Number of Shares Outstanding, Diluted 6M shares +13%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 1.37M USD
Research and Development Expense 3K USD -99.6%
General and Administrative Expense 4.17M USD +8.82%
Operating Income (Loss) -20.8M USD -44.4%
Nonoperating Income (Expense) -3.79M USD +52.3%
Net Income (Loss) Attributable to Parent -24.6M USD -9.97%
Earnings Per Share, Basic -4.58 USD/shares -4.81%
Earnings Per Share, Diluted -4.15 USD/shares +5.03%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.96M USD -79.5%
Marketable Securities, Current 5.12M USD -79%
Cash, Cash Equivalents, and Short-term Investments 13K USD
Assets, Current 25.4M USD -43.4%
Other Long-term Investments 20.9M USD
Property, Plant and Equipment, Net 317K USD -10.2%
Operating Lease, Right-of-Use Asset 3.24M USD -10.4%
Assets 52.2M USD -29.6%
Employee-related Liabilities, Current 177K USD -86.8%
Liabilities, Current 1.6M USD -7.21%
Operating Lease, Liability, Noncurrent 2.93M USD
Liabilities 4.53M USD -11%
Retained Earnings (Accumulated Deficit) -214M USD -13%
Stockholders' Equity Attributable to Parent 47.7M USD -31%
Liabilities and Equity 52.2M USD -29.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -8.59M USD -115%
Net Cash Provided by (Used in) Financing Activities -939K USD +86.9%
Net Cash Provided by (Used in) Investing Activities 7.72M USD
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 6M shares +24.5%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -30.3M USD +6.32%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.96M USD -79.5%
Deferred Tax Assets, Valuation Allowance 55.9M USD +13.9%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 57.2M USD +15.6%
Operating Lease, Liability 3.35M USD
Depreciation 26K USD +271%
Payments to Acquire Property, Plant, and Equipment 361K USD
Lessee, Operating Lease, Liability, to be Paid 4.54M USD -11.2%
Property, Plant and Equipment, Gross 427K USD
Operating Lease, Liability, Current 419K USD
Lessee, Operating Lease, Liability, to be Paid, Year Two 685K USD -0.44%
Lessee, Operating Lease, Liability, to be Paid, Year One 685K USD -8.67%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.19M USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 685K USD -0.44%
Deferred Tax Assets, Operating Loss Carryforwards 33.1M USD +26.2%
Deferred Federal Income Tax Expense (Benefit) 3.82M USD +5.58%
Preferred Stock, Shares Authorized 50M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 766K USD +11.3%
Operating Lease, Payments 187K USD +450%
Additional Paid in Capital 262M USD +1.22%
Deferred Tax Assets, Net of Valuation Allowance 1.22M USD +272%
Share-based Payment Arrangement, Expense 100K USD -98%
Deferred State and Local Income Tax Expense (Benefit) 3.01M USD -37.6%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%